Inovio initiates phase 1 clinical trial of its covid-19 vaccine

Inovio initiates phase 1 clinical trial of its covid-19 vaccine and plans first dose today.inovio - u.s. fda accepted co's ind application for ino-4800, its dna vaccine candidate designed to prevent covid-19 infection.inovio pharmaceuticals inc - phase 1 study of ino-4800 will enroll up to 40 healthy adult volunteers.inovio pharmaceuticals inc - initial immune responses and safety data from study are expected by late summer.inovio- to date, preclinical results for co's covid vaccine consistent with co's completed phase 1 vaccine study for middle east respiratory syndrome.inovio pharmaceuticals inc - plans to have one million doses of vaccine available by year-end for additional trials and emergency use.
INO Ratings Summary
INO Quant Ranking